Biotech

All Articles

Cassava pays for $40M over presumably deceiving Alzheimer's upgrade

.Cassava Sciences has accepted pay for $40 million to address an inspection into cases it created de...

Merck bags alternatives on Evaxion's AI-designed vaccine applicants

.Merck &amp Co. has gotten options on pair of Evaxion Biotech vaccination candidates, paying $3.2 mi...

Enanta's RSV antiviral crushes virus-like lots in challenge study

.Enanta Pharmaceuticals has connected its own respiratory system syncytial virus (RSV) antiviral to ...

Biogen containers SAGE-324 cooperation after important tremor fall short

.Biogen has actually conducted the last rites to its cooperation along with Sage Rehabs on SAGE-324,...

AbbVie Parkinson's drug coming from $8.7 B Cerevel purchase ratings

.On the same time that some Parkinson's health condition drugs are being questioned, AbbVie has actu...

Arch closes $3B-plus fund to encourage biopharma startups

.On the heels of a $3 billion fund coming from Bain Resources Lifestyle Sciences, Arch Venture Allie...

Orion to make use of Aitia's 'digital doubles' to find new cancer medicines

.Finnish biotech Orion has actually snooped prospective in Aitia's "digital double" tech to cultivat...

Windtree's surprise med brings up blood pressure in newest period 2 win

.While Windtree Rehabs has strained to grow the economic roots needed to have to survive, a stage 2 ...

2 cancer biotechs combine, generating global footprint

.OncoC4 is actually taking AcroImmune-- and its own internal clinical manufacturing capabilities-- u...

Amgen records 1st stage 3 win for $400M chronic eczema drug

.Amgen has discussed (PDF) the first phase 3 records on its $400 million dermatitis medication, link...